Keros Therapeutics, Inc. Profile Avatar - Palmy Investing

Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. T…

Biotechnology
US, Lexington [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Keros Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of KROS's Analysis
CIK: 1664710 CUSIP: 492327101 ISIN: US4923271013 LEI: - UEI: -
Secondary Listings
KROS has no secondary listings inside our databases.